Perdagangan Vir Biotechnology VIR

Jual
 Beli

VirBiotechnology diagram langsung

5m 15m 30m 1h 4h 1d 1w

Dasar-dasar Instrumen

Weekly Search
Weekly
Daily
Tanggal Tutup Ubah Ubah (%) Buka Tinggi Rendah

VirBiotechnology news

Berita Terkini

Tampilkan lebih banyak
Ava Grace 2025 Oct 18, 00:00

Market Overview: Gold Surges Amidst Economic Uncertainty Grips Global Markets

Sophia Claire 2025 Oct 18, 00:00

Trump-Putin Alaska Summit: How It Shaped a Shift in US Ukraine Policy

Sophia Claire 2025 Oct 18, 00:00

Israel and Hamas Trade Accusations of Ceasefire Violations; Rafah Crossing Reopening Planned Amid Worsening Humanitarian Crisis in Gaza

Emma Rose 2025 Oct 18, 00:00

Fed's Rate Cut Outlook: Balancing Employment vs. Inflation Concerns

Liam James 2025 Oct 18, 00:00

US Jobless Claims Analysis Amid Government Shutdown: A Closer Look

Emma Rose 2025 Oct 18, 00:00

Israeli Airstrike Kills Houthi Commander: Strategic Implications and Potential Repercussions

Liam James 2025 Oct 18, 00:00

Yen Strengthens as Dollar/Yen Drops Below 150 Amid US Bank Concerns

Ava Grace 2025 Oct 18, 00:00

Gold Price Surge: A Hot Topic at IMF and World Bank Meetings

Info

Spread

0.05

Spread (%)

0.8666 %

Leverage

1:10

Bunga Overnight Beli

-0.0597 %

Bunga Overnight Jual

-0.0292 %

Mata Uang

USD

Jam Trading

Pasar tutup

Senin

13:31 - 19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Kamis

13:31-19:59

Jumat

13:31-19:59

Analisis dan Statistik

Buka

---

Sebelumnya Tutup

---

52 Minggu Tigg/Rdh

--- – ---

Kapitalisasi Pasar

805715328

Saham yang Beredar

138916426

Tanggal Penghasilan (Berikutnya)

0000-00-00

Hasil Div

Tanggal Non-Dividen

Proyeksi tingkat dividen tahunan

0

Proyeksi hasil dividen tahunan

0

EPS

-4.01

Pelajari lebih lanjut tentang instrumen ini

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Instrumen Terkait

Aset
Jual
Beli
Ubah (%)

Lakukan Trading

Lakukan Trading

Lakukan Trading

Lakukan Trading
view_all_instruments

latest_education_articles

Tampilkan lebih banyak
Trustpilot